Factor XIII

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Factor XIII crosslinks fibrin
Factor XIII crosslinks fibrin
coagulation factor XIII, A1 polypeptide
Identifiers
Symbol F13A1
Alt. Symbols F13A
Entrez 2162
HUGO 3531
OMIM 134570
RefSeq NM_000129
UniProt P00488
Other data
Locus Chr. 6 p24.2-p23
coagulation factor XIII, B polypeptide
Identifiers
Symbol F13B
Entrez 2165
HUGO 3534
OMIM 134580
RefSeq NM_001994
UniProt P05160
Other data
Locus Chr. 1 q31-q32.1

WikiDoc Resources for

Factor XIII

Articles

Most recent articles on Factor XIII

Most cited articles on Factor XIII

Review articles on Factor XIII

Articles on Factor XIII in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Factor XIII

Images of Factor XIII

Photos of Factor XIII

Podcasts & MP3s on Factor XIII

Videos on Factor XIII

Evidence Based Medicine

Cochrane Collaboration on Factor XIII

Bandolier on Factor XIII

TRIP on Factor XIII

Clinical Trials

Ongoing Trials on Factor XIII at Clinical Trials.gov

Trial results on Factor XIII

Clinical Trials on Factor XIII at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Factor XIII

NICE Guidance on Factor XIII

NHS PRODIGY Guidance

FDA on Factor XIII

CDC on Factor XIII

Books

Books on Factor XIII

News

Factor XIII in the news

Be alerted to news on Factor XIII

News trends on Factor XIII

Commentary

Blogs on Factor XIII

Definitions

Definitions of Factor XIII

Patient Resources / Community

Patient resources on Factor XIII

Discussion groups on Factor XIII

Patient Handouts on Factor XIII

Directions to Hospitals Treating Factor XIII

Risk calculators and risk factors for Factor XIII

Healthcare Provider Resources

Symptoms of Factor XIII

Causes & Risk Factors for Factor XIII

Diagnostic studies for Factor XIII

Treatment of Factor XIII

Continuing Medical Education (CME)

CME Programs on Factor XIII

International

Factor XIII en Espanol

Factor XIII en Francais

Businness

Factor XIII in the Marketplace

Patents on Factor XIII

Experimental / Informatics

List of terms related to Factor XIII

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Factor XIII or fibrin stabilizing factor is an enzyme (EC 2.3.2.13) of the blood coagulation system that crosslinks fibrin. When thrombin has converted fibrinogen to fibrin, the latter forms a proteinaceous network in which every E-unit is crosslinked to only one D-unit. Factor XIII is activated by thrombin into factor XIIIa; its activation into Factor XIIIa requires calcium as a cofactor.

FXIII is known also as Laki-Lorand factor, after the scientists who first proposed its existence in 1948.[1] A 2005 conference recommended standardization of nomenclature.[1]

Genetics

Zymogene factor XIII is a 320000 Mr glycoprotein tetramer consisting of twice two subunits (2 A and 2 B),[1] the genes for which are on different chromosomes:

  • A subunit (6p25-p24). The transglutaminase part; this adds an alkyl group to the nitrogen on a glutamine residue, which binds in turn with a lysine on the other chain. The molecular weight of the A chain is approximately 83000.
  • B subunit (1q31-q32.1). This has no clear enzymatic activity, and may serve as a carrier for the A subunit. The molecular weight of the B chain is approximately 76500.

Physiology

Typical concentrations of FXIII in plasma is 10 μg/ml (2A2B heterodimer), while the concentration of free B chain is 22 μg/ml. FXIII has a long half life, ranging from 5-9 days. It is present in plasma, platelets, and monocytes, as well as macrophages and bone marrow precursors of these cell types.[1]

A clot that has not been stabilized by FXIIIa is soluble in 5 mol/L urea, while a stabilized clot is resistant to this phenomenon.[1]

Diagnostic use

Factor XIII levels are not measured routinely, but may be considered in patients with an unexplained bleeding tendency. As the enzyme is quite specific for monocytes and macrophages, determination of the presence of factor XIII may be used to identify and classify malignant diseases involving these cells.[1]

See also

References


External links

de:Fibrinstabilisierender Faktor

fr:Facteur Laki-Lorand sv:Faktor XIII

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools